Harer Kimberly N, Hasler William L
Dr Harer is a clinical lecturer and Dr Hasler is a professor in the Division of Gastroenterology in the University of Michigan Health System in Ann Arbor, Michigan.
Gastroenterol Hepatol (N Y). 2020 Feb;16(2):66-74.
The community prevalence of dyspepsia ranges from 20% to 40%, and dyspepsia accounts for 3% to 5% of primary care visits. Dyspepsia symptoms include epigastric pain, epigastric burning, postprandial fullness, early satiety, epigastric bloating, nausea, and belching. Functional dyspepsia is diagnosed when an organic etiology for the symptoms is not identified. Diagnostic symptom-based criteria are defined by Rome IV. Functional dyspepsia is further subclassified into postprandial distress syndrome and epigastric pain syndrome based on the predominance of post-prandial bloating and fullness vs epigastric pain. Evaluation of functional dyspepsia is driven by patient age and the presence of red-flag symptoms, such as patients over age 60 years or those with anemia undergoing evaluation with esophagogastroduodenoscopy. infection should be excluded in all patients. Treatment options include proton pump inhibitors, neuromodulators, and prokinetics; however, the evidence supporting these therapies is weak, and the response rate is less than robust.
消化不良的社区患病率在20%至40%之间,消化不良占初级保健就诊人数的3%至5%。消化不良症状包括上腹部疼痛、上腹部烧灼感、餐后饱胀、早饱、上腹部胀气、恶心和嗳气。当未发现症状的器质性病因时,可诊断为功能性消化不良。基于症状的诊断标准由罗马IV定义。根据餐后腹胀和饱胀与上腹部疼痛的优势,功能性消化不良进一步细分为餐后不适综合征和上腹部疼痛综合征。功能性消化不良的评估取决于患者年龄和警示症状的存在,如60岁以上的患者或正在接受食管胃十二指肠镜检查评估的贫血患者。所有患者均应排除感染。治疗选择包括质子泵抑制剂、神经调节剂和促动力药;然而,支持这些疗法的证据不足,有效率也不高。